FDA Inspection 1260195 — VKT Pharma Private Limited

VKT Pharma Private Limited — FEI 3013791804

The FDA completed an inspection of VKT Pharma Private Limited on February 7, 2025 in Srikakulam. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 7, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Srikakulam (India)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed